1. Home
  2. G vs BLCO Comparison

G vs BLCO Comparison

Compare G & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$31.17

Market Cap

5.4B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.81

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
G
BLCO
Founded
1997
1853
Country
Bermuda
Canada
Employees
140000
N/A
Industry
Professional Services
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.9B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
G
BLCO
Price
$31.17
$15.81
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$49.50
$18.45
AVG Volume (30 Days)
3.3M
469.3K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
2.21%
N/A
EPS Growth
9.82
N/A
EPS
0.86
N/A
Revenue
$2,279,438,000.00
$5,101,000,000.00
Revenue This Year
$9.20
$8.65
Revenue Next Year
$7.27
$5.59
P/E Ratio
$37.07
N/A
Revenue Growth
N/A
6.47
52 Week Low
$28.78
$11.22
52 Week High
$48.64
$18.92

Technical Indicators

Market Signals
Indicator
G
BLCO
Relative Strength Index (RSI) 39.54 42.13
Support Level $28.78 $15.67
Resistance Level $38.03 $16.41
Average True Range (ATR) 1.49 0.38
MACD 0.18 -0.00
Stochastic Oscillator 40.59 18.00

Price Performance

Historical Comparison
G
BLCO

About G Genpact Limited

Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: